vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and OneStream, Inc. (OS). Click either name above to swap in a different company.

OneStream, Inc. is the larger business by last-quarter revenue ($163.7M vs $104.5M, roughly 1.6× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 23.6%). OneStream, Inc. produced more free cash flow last quarter ($25.6M vs $-35.5M). Over the past eight quarters, OneStream, Inc.'s revenue compounded faster (21.8% CAGR vs 21.7%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Blue Stream provides cable television, cable telephone, DVR, and up to 1 GIG Internet speed broadband services to customers in the Florida communities of Coral Springs and Weston.

IMCR vs OS — Head-to-Head

Bigger by revenue
OS
OS
1.6× larger
OS
$163.7M
$104.5M
IMCR
Growing faster (revenue YoY)
IMCR
IMCR
+0.7% gap
IMCR
24.3%
23.6%
OS
More free cash flow
OS
OS
$61.2M more FCF
OS
$25.6M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
OS
OS
Annualised
OS
21.8%
21.7%
IMCR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
OS
OS
Revenue
$104.5M
$163.7M
Net Profit
$999.0K
Gross Margin
97.4%
69.8%
Operating Margin
-18.8%
-3.2%
Net Margin
0.6%
Revenue YoY
24.3%
23.6%
Net Profit YoY
EPS (diluted)
$-0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
OS
OS
Q4 25
$104.5M
$163.7M
Q3 25
$103.7M
$154.3M
Q2 25
$98.0M
$147.6M
Q1 25
$93.9M
$136.3M
Q4 24
$84.1M
$132.5M
Q3 24
$80.2M
$129.1M
Q2 24
$75.4M
$117.5M
Q1 24
$70.5M
$110.3M
Net Profit
IMCR
IMCR
OS
OS
Q4 25
$999.0K
Q3 25
$-177.0K
$-8.8M
Q2 25
$-10.3M
$-18.4M
Q1 25
$5.0M
$-24.0M
Q4 24
Q3 24
$8.7M
$-171.9M
Q2 24
$-11.6M
$-7.8M
Q1 24
$-24.4M
$-5.0M
Gross Margin
IMCR
IMCR
OS
OS
Q4 25
97.4%
69.8%
Q3 25
99.5%
68.1%
Q2 25
98.9%
68.6%
Q1 25
99.1%
68.0%
Q4 24
99.6%
66.8%
Q3 24
99.4%
50.1%
Q2 24
97.7%
68.5%
Q1 24
99.7%
69.1%
Operating Margin
IMCR
IMCR
OS
OS
Q4 25
-18.8%
-3.2%
Q3 25
-6.9%
-11.3%
Q2 25
-15.2%
-21.8%
Q1 25
-3.9%
-29.3%
Q4 24
-23.1%
-35.8%
Q3 24
-10.6%
-197.6%
Q2 24
-21.2%
-9.8%
Q1 24
-37.6%
-4.9%
Net Margin
IMCR
IMCR
OS
OS
Q4 25
0.6%
Q3 25
-0.2%
-5.7%
Q2 25
-10.5%
-12.5%
Q1 25
5.4%
-17.6%
Q4 24
Q3 24
10.9%
-133.1%
Q2 24
-15.4%
-6.7%
Q1 24
-34.7%
-4.5%
EPS (diluted)
IMCR
IMCR
OS
OS
Q4 25
$-0.61
Q3 25
$0.00
Q2 25
$-0.20
Q1 25
$0.10
Q4 24
$-0.47
Q3 24
$0.17
$-1.06
Q2 24
$-0.23
Q1 24
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
OS
OS
Cash + ST InvestmentsLiquidity on hand
$864.2M
$693.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$381.0M
$504.7M
Total Assets
$1.1B
$1.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
OS
OS
Q4 25
$864.2M
$693.6M
Q3 25
$892.4M
$653.9M
Q2 25
$882.8M
$652.1M
Q1 25
$837.0M
$593.9M
Q4 24
$820.4M
$544.2M
Q3 24
$901.3M
$495.5M
Q2 24
$859.6M
$140.5M
Q1 24
$832.8M
Total Debt
IMCR
IMCR
OS
OS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$438.7M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
OS
OS
Q4 25
$381.0M
$504.7M
Q3 25
$396.6M
$472.1M
Q2 25
$388.5M
$458.2M
Q1 25
$378.5M
$412.9M
Q4 24
$360.7M
$386.2M
Q3 24
$377.8M
$458.2M
Q2 24
$359.1M
$97.5M
Q1 24
$359.5M
$102.5M
Total Assets
IMCR
IMCR
OS
OS
Q4 25
$1.1B
$1.0B
Q3 25
$1.1B
$949.4M
Q2 25
$1.1B
$910.5M
Q1 25
$1.0B
$867.3M
Q4 24
$1.0B
$823.2M
Q3 24
$1.1B
$750.1M
Q2 24
$1.0B
$379.7M
Q1 24
$994.0M
Debt / Equity
IMCR
IMCR
OS
OS
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
1.16×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
OS
OS
Operating Cash FlowLast quarter
$-32.7M
$25.8M
Free Cash FlowOCF − Capex
$-35.5M
$25.6M
FCF MarginFCF / Revenue
-34.0%
15.7%
Capex IntensityCapex / Revenue
2.8%
0.1%
Cash ConversionOCF / Net Profit
25.79×
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$95.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
OS
OS
Q4 25
$-32.7M
$25.8M
Q3 25
$-4.5M
$5.0M
Q2 25
$26.0M
$29.7M
Q1 25
$435.0K
$36.2M
Q4 24
$-14.0M
Q3 24
$21.1M
$2.4M
Q2 24
$23.5M
$8.1M
Q1 24
$-4.6M
$25.5M
Free Cash Flow
IMCR
IMCR
OS
OS
Q4 25
$-35.5M
$25.6M
Q3 25
$-5.2M
$4.8M
Q2 25
$25.6M
$29.4M
Q1 25
$137.0K
$35.8M
Q4 24
$-17.5M
Q3 24
$20.3M
$1.3M
Q2 24
$23.1M
$7.7M
Q1 24
$-5.0M
$24.9M
FCF Margin
IMCR
IMCR
OS
OS
Q4 25
-34.0%
15.7%
Q3 25
-5.0%
3.1%
Q2 25
26.1%
19.9%
Q1 25
0.1%
26.3%
Q4 24
-20.9%
Q3 24
25.3%
1.0%
Q2 24
30.7%
6.6%
Q1 24
-7.1%
22.5%
Capex Intensity
IMCR
IMCR
OS
OS
Q4 25
2.8%
0.1%
Q3 25
0.7%
0.1%
Q2 25
0.4%
0.2%
Q1 25
0.3%
0.3%
Q4 24
4.3%
Q3 24
1.0%
0.8%
Q2 24
0.4%
0.3%
Q1 24
0.6%
0.6%
Cash Conversion
IMCR
IMCR
OS
OS
Q4 25
25.79×
Q3 25
Q2 25
Q1 25
0.09×
Q4 24
Q3 24
2.42×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

OS
OS

Subscription And Circulation$150.3M92%
Professional Services And Other$9.4M6%
License$4.0M2%

Related Comparisons